These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6334206)

  • 21. Serum complement abnormalities in the antinuclear antibody-positive relatives of children with systemic lupus erythematosus.
    Lehman TJ; Hanson V; Singsen BH; Kornreich HK; Bernstein B; King KK
    Arthritis Rheum; 1979 Sep; 22(9):954-8. PubMed ID: 314291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
    Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A
    Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cryoglobulins. I. Studies on the nature, incidence, and clinical significance of serum cryoproteins in glomerulonephritis.
    McIntosh RM; Kaufman DB; Kulvinskas C; Grossman BJ
    J Lab Clin Med; 1970 Apr; 75(4):566-77. PubMed ID: 4910479
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum complement levels and perinatal outcome in pregnancies complicated by systemic lupus erythematosus.
    Devoe LD; Loy GL
    Obstet Gynecol; 1984 Jun; 63(6):796-800. PubMed ID: 6728360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunohistological aspects of lupus nephropathy. Clinical and prognostic significance].
    Bertoli S; Ragni A; Porri MT; Scalia P; Mazzucco G; Stratta P; Robaudo C; Busnach G; Mariani E; Barbiano Di Belgiojoso G
    Minerva Nefrol; 1981; 28(1):21-5. PubMed ID: 7027085
    [No Abstract]   [Full Text] [Related]  

  • 26. Diffuse proliferative lupus glomerulonephritis. Determination of prognostic significance of clinical, laboratory and pathologic factors.
    Magil AB; Ballon HS; Chan V; Lirenman DS; Rae A; Sutton RA
    Medicine (Baltimore); 1984 Jul; 63(4):210-20. PubMed ID: 6377004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tendon rupture in systemic lupus erythematosus.
    Khan MA; Ballou SP
    J Rheumatol; 1981; 8(2):308-10. PubMed ID: 6971935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Circulating immune complexes and C3 in patients with systemic lupus erythematosus. The relationship between clinical manifestations and nephropathy (author's transl)].
    Rodríguez-Valverde V; Peña Sagredo JL; Orte Martínez J; Novo Fernández MJ; Sánchez Andrada S; Sampedro Alvarez J
    Med Clin (Barc); 1982 May; 78(9):353-7. PubMed ID: 6808263
    [No Abstract]   [Full Text] [Related]  

  • 29. [The significance of antibodies to DNA nucleoprotein, complement and granulocyte phagocytosis in the production of LE cells].
    Horvat Z; Cikes N
    Lijec Vjesn; 1983 Oct; 105(10):396-9. PubMed ID: 6197600
    [No Abstract]   [Full Text] [Related]  

  • 30. [Abnormal findings in the blood in SLE].
    Ofuji T; Miyawaki S; Sato H; Morita M; Nishishita S
    Nihon Rinsho; 1968 Dec; 26(12):3449-58. PubMed ID: 4181084
    [No Abstract]   [Full Text] [Related]  

  • 31. Repeat Testing of Antibodies and Complements in Systemic Lupus Erythematosus: When Is It Enough?
    Raissi TC; Hewson C; Pope JE
    J Rheumatol; 2018 Jun; 45(6):827-834. PubMed ID: 29657153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients.
    Boeckler P; Meyer A; Uring-Lambert B; Goetz J; Cribier B; Hauptmann G; Lipsker D
    Clin Immunol; 2006 Nov; 121(2):198-202. PubMed ID: 16987709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune complexes in the pericardial fluid in systemic lupus erythematosus.
    Quismorio FP
    Arch Intern Med; 1980 Jan; 140(1):112-4. PubMed ID: 6965447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malar rash caused by metal allergy in a patient with systemic lupus erythematosus.
    Kosboth M; Chin-Loy A; Lyons R; Wesson SK; Reeves WH
    Nat Clin Pract Rheumatol; 2007 Apr; 3(4):240-5. PubMed ID: 17396110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The spectrum of lupus nephropathy].
    Peña Sánchez de Rivera JM; Vázquez Rodríguez JJ; Calvo Manuel F; Redondo Sánchez C; Barbado Hernández FJ; Gil Aguado A; Ortíz Vázquez J
    Med Clin (Barc); 1980 Oct; 75(6):229-34. PubMed ID: 7421356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disease activity in systemic lupus erythematosus. Value of laboratory criteria.
    Claudy AL; Touraine JL; Alario A
    Clin Exp Dermatol; 1979 Dec; 4(4):435-43. PubMed ID: 317029
    [No Abstract]   [Full Text] [Related]  

  • 37. Modulation of complement by autoimmune antibodies isolated from sera of patients with membranoproliferative glomerulonephritis and systemic lupus erythematosus.
    Daha MR; Van Es LA
    Neth J Med; 1982; 25(7):202-7. PubMed ID: 6924073
    [No Abstract]   [Full Text] [Related]  

  • 38. Cryoglobulins in rheumatoid arthritis.
    Weisman M; Zvaifler N
    Rheumatology; 1975; 6():60-70. PubMed ID: 1081731
    [No Abstract]   [Full Text] [Related]  

  • 39. Useful laboratory measurements in the management of systemic lupus erythematosus.
    Morrow WJ; Isenberg DA; Todd-Pokropek A; Parry HF; Snaith ML
    Q J Med; 1982; 51(202):125-38. PubMed ID: 6981121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of autoimmune patients.
    Gergely P
    Acta Biomed Ateneo Parmense; 1991; 62(3-4):125-30. PubMed ID: 1840372
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.